Request for Covid-19 Impact Assessment of this Report
The United States Dermatology Drugs for Pets market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermatology Drugs for Pets market, reaching US$ million by the year 2028. As for the Europe Dermatology Drugs for Pets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Dermatology Drugs for Pets players cover Bayer Animal Health, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, and Zoetis Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drugs for Pets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antibiotics
Antifungal Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pets Clinics
Pets Hospitals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Ceva Sante Animale
Zoetis Inc.
Elanco
IDEXX Laboratories
Merial
Vetoquinol S.A.panies
Virbac S.A.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology Drugs for Pets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Dermatology Drugs for Pets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Dermatology Drugs for Pets by Country/Region, 2017, 2022 & 2028
2.2 Dermatology Drugs for Pets Segment by Type
2.2.1 Antibiotics
2.2.2 Antifungal Drugs
2.2.3 Others
2.3 Dermatology Drugs for Pets Sales by Type
2.3.1 Global Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
2.3.2 Global Dermatology Drugs for Pets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Dermatology Drugs for Pets Sale Price by Type (2017-2022)
2.4 Dermatology Drugs for Pets Segment by Application
2.4.1 Pets Clinics
2.4.2 Pets Hospitals
2.4.3 Others
2.5 Dermatology Drugs for Pets Sales by Application
2.5.1 Global Dermatology Drugs for Pets Sale Market Share by Application (2017-2022)
2.5.2 Global Dermatology Drugs for Pets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Dermatology Drugs for Pets Sale Price by Application (2017-2022)
3 Global Dermatology Drugs for Pets by Company
3.1 Global Dermatology Drugs for Pets Breakdown Data by Company
3.1.1 Global Dermatology Drugs for Pets Annual Sales by Company (2020-2022)
3.1.2 Global Dermatology Drugs for Pets Sales Market Share by Company (2020-2022)
3.2 Global Dermatology Drugs for Pets Annual Revenue by Company (2020-2022)
3.2.1 Global Dermatology Drugs for Pets Revenue by Company (2020-2022)
3.2.2 Global Dermatology Drugs for Pets Revenue Market Share by Company (2020-2022)
3.3 Global Dermatology Drugs for Pets Sale Price by Company
3.4 Key Manufacturers Dermatology Drugs for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermatology Drugs for Pets Product Location Distribution
3.4.2 Players Dermatology Drugs for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Dermatology Drugs for Pets by Geographic Region
4.1 World Historic Dermatology Drugs for Pets Market Size by Geographic Region (2017-2022)
4.1.1 Global Dermatology Drugs for Pets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Dermatology Drugs for Pets Annual Revenue by Geographic Region
4.2 World Historic Dermatology Drugs for Pets Market Size by Country/Region (2017-2022)
4.2.1 Global Dermatology Drugs for Pets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Dermatology Drugs for Pets Annual Revenue by Country/Region
4.3 Americas Dermatology Drugs for Pets Sales Growth
4.4 APAC Dermatology Drugs for Pets Sales Growth
4.5 Europe Dermatology Drugs for Pets Sales Growth
4.6 Middle East & Africa Dermatology Drugs for Pets Sales Growth
5 Americas
5.1 Americas Dermatology Drugs for Pets Sales by Country
5.1.1 Americas Dermatology Drugs for Pets Sales by Country (2017-2022)
5.1.2 Americas Dermatology Drugs for Pets Revenue by Country (2017-2022)
5.2 Americas Dermatology Drugs for Pets Sales by Type
5.3 Americas Dermatology Drugs for Pets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dermatology Drugs for Pets Sales by Region
6.1.1 APAC Dermatology Drugs for Pets Sales by Region (2017-2022)
6.1.2 APAC Dermatology Drugs for Pets Revenue by Region (2017-2022)
6.2 APAC Dermatology Drugs for Pets Sales by Type
6.3 APAC Dermatology Drugs for Pets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Dermatology Drugs for Pets by Country
7.1.1 Europe Dermatology Drugs for Pets Sales by Country (2017-2022)
7.1.2 Europe Dermatology Drugs for Pets Revenue by Country (2017-2022)
7.2 Europe Dermatology Drugs for Pets Sales by Type
7.3 Europe Dermatology Drugs for Pets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dermatology Drugs for Pets by Country
8.1.1 Middle East & Africa Dermatology Drugs for Pets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Dermatology Drugs for Pets Revenue by Country (2017-2022)
8.2 Middle East & Africa Dermatology Drugs for Pets Sales by Type
8.3 Middle East & Africa Dermatology Drugs for Pets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dermatology Drugs for Pets
10.3 Manufacturing Process Analysis of Dermatology Drugs for Pets
10.4 Industry Chain Structure of Dermatology Drugs for Pets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dermatology Drugs for Pets Distributors
11.3 Dermatology Drugs for Pets Customer
12 World Forecast Review for Dermatology Drugs for Pets by Geographic Region
12.1 Global Dermatology Drugs for Pets Market Size Forecast by Region
12.1.1 Global Dermatology Drugs for Pets Forecast by Region (2023-2028)
12.1.2 Global Dermatology Drugs for Pets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dermatology Drugs for Pets Forecast by Type
12.7 Global Dermatology Drugs for Pets Forecast by Application
13 Key Players Analysis
13.1 Bayer Animal Health
13.1.1 Bayer Animal Health Company Information
13.1.2 Bayer Animal Health Dermatology Drugs for Pets Product Offered
13.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Animal Health Main Business Overview
13.1.5 Bayer Animal Health Latest Developments
13.2 Boehringer Ingelheim Vetmedica
13.2.1 Boehringer Ingelheim Vetmedica Company Information
13.2.2 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Offered
13.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boehringer Ingelheim Vetmedica Main Business Overview
13.2.5 Boehringer Ingelheim Vetmedica Latest Developments
13.3 Ceva Sante Animale
13.3.1 Ceva Sante Animale Company Information
13.3.2 Ceva Sante Animale Dermatology Drugs for Pets Product Offered
13.3.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Ceva Sante Animale Main Business Overview
13.3.5 Ceva Sante Animale Latest Developments
13.4 Zoetis Inc.
13.4.1 Zoetis Inc. Company Information
13.4.2 Zoetis Inc. Dermatology Drugs for Pets Product Offered
13.4.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Zoetis Inc. Main Business Overview
13.4.5 Zoetis Inc. Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Dermatology Drugs for Pets Product Offered
13.5.3 Elanco Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 IDEXX Laboratories
13.6.1 IDEXX Laboratories Company Information
13.6.2 IDEXX Laboratories Dermatology Drugs for Pets Product Offered
13.6.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 IDEXX Laboratories Main Business Overview
13.6.5 IDEXX Laboratories Latest Developments
13.7 Merial
13.7.1 Merial Company Information
13.7.2 Merial Dermatology Drugs for Pets Product Offered
13.7.3 Merial Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merial Main Business Overview
13.7.5 Merial Latest Developments
13.8 Vetoquinol S.A.panies
13.8.1 Vetoquinol S.A.panies Company Information
13.8.2 Vetoquinol S.A.panies Dermatology Drugs for Pets Product Offered
13.8.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Vetoquinol S.A.panies Main Business Overview
13.8.5 Vetoquinol S.A.panies Latest Developments
13.9 Virbac S.A.
13.9.1 Virbac S.A. Company Information
13.9.2 Virbac S.A. Dermatology Drugs for Pets Product Offered
13.9.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Virbac S.A. Main Business Overview
13.9.5 Virbac S.A. Latest Developments
14 Research Findings and Conclusion
Table 1. Dermatology Drugs for Pets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Dermatology Drugs for Pets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Antifungal Drugs
Table 5. Major Players of Others
Table 6. Global Dermatology Drugs for Pets Sales by Type (2017-2022) & (K Units)
Table 7. Global Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
Table 8. Global Dermatology Drugs for Pets Revenue by Type (2017-2022) & ($ million)
Table 9. Global Dermatology Drugs for Pets Revenue Market Share by Type (2017-2022)
Table 10. Global Dermatology Drugs for Pets Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Dermatology Drugs for Pets Sales by Application (2017-2022) & (K Units)
Table 12. Global Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Table 13. Global Dermatology Drugs for Pets Revenue by Application (2017-2022)
Table 14. Global Dermatology Drugs for Pets Revenue Market Share by Application (2017-2022)
Table 15. Global Dermatology Drugs for Pets Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Dermatology Drugs for Pets Sales by Company (2020-2022) & (K Units)
Table 17. Global Dermatology Drugs for Pets Sales Market Share by Company (2020-2022)
Table 18. Global Dermatology Drugs for Pets Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Dermatology Drugs for Pets Revenue Market Share by Company (2020-2022)
Table 20. Global Dermatology Drugs for Pets Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Dermatology Drugs for Pets Producing Area Distribution and Sales Area
Table 22. Players Dermatology Drugs for Pets Products Offered
Table 23. Dermatology Drugs for Pets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Dermatology Drugs for Pets Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Dermatology Drugs for Pets Sales Market Share Geographic Region (2017-2022)
Table 28. Global Dermatology Drugs for Pets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Dermatology Drugs for Pets Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Dermatology Drugs for Pets Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Dermatology Drugs for Pets Sales Market Share by Country/Region (2017-2022)
Table 32. Global Dermatology Drugs for Pets Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Dermatology Drugs for Pets Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Dermatology Drugs for Pets Sales by Country (2017-2022) & (K Units)
Table 35. Americas Dermatology Drugs for Pets Sales Market Share by Country (2017-2022)
Table 36. Americas Dermatology Drugs for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Dermatology Drugs for Pets Revenue Market Share by Country (2017-2022)
Table 38. Americas Dermatology Drugs for Pets Sales by Type (2017-2022) & (K Units)
Table 39. Americas Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
Table 40. Americas Dermatology Drugs for Pets Sales by Application (2017-2022) & (K Units)
Table 41. Americas Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Table 42. APAC Dermatology Drugs for Pets Sales by Region (2017-2022) & (K Units)
Table 43. APAC Dermatology Drugs for Pets Sales Market Share by Region (2017-2022)
Table 44. APAC Dermatology Drugs for Pets Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Dermatology Drugs for Pets Revenue Market Share by Region (2017-2022)
Table 46. APAC Dermatology Drugs for Pets Sales by Type (2017-2022) & (K Units)
Table 47. APAC Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
Table 48. APAC Dermatology Drugs for Pets Sales by Application (2017-2022) & (K Units)
Table 49. APAC Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Table 50. Europe Dermatology Drugs for Pets Sales by Country (2017-2022) & (K Units)
Table 51. Europe Dermatology Drugs for Pets Sales Market Share by Country (2017-2022)
Table 52. Europe Dermatology Drugs for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Dermatology Drugs for Pets Revenue Market Share by Country (2017-2022)
Table 54. Europe Dermatology Drugs for Pets Sales by Type (2017-2022) & (K Units)
Table 55. Europe Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
Table 56. Europe Dermatology Drugs for Pets Sales by Application (2017-2022) & (K Units)
Table 57. Europe Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Dermatology Drugs for Pets Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Dermatology Drugs for Pets Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Dermatology Drugs for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Dermatology Drugs for Pets Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Dermatology Drugs for Pets Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Dermatology Drugs for Pets Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Dermatology Drugs for Pets Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Dermatology Drugs for Pets
Table 67. Key Market Challenges & Risks of Dermatology Drugs for Pets
Table 68. Key Industry Trends of Dermatology Drugs for Pets
Table 69. Dermatology Drugs for Pets Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Dermatology Drugs for Pets Distributors List
Table 72. Dermatology Drugs for Pets Customer List
Table 73. Global Dermatology Drugs for Pets Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Dermatology Drugs for Pets Sales Market Forecast by Region
Table 75. Global Dermatology Drugs for Pets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Dermatology Drugs for Pets Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Dermatology Drugs for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Dermatology Drugs for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Dermatology Drugs for Pets Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Dermatology Drugs for Pets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Dermatology Drugs for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Dermatology Drugs for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Dermatology Drugs for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Dermatology Drugs for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Dermatology Drugs for Pets Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Dermatology Drugs for Pets Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Dermatology Drugs for Pets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Dermatology Drugs for Pets Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Dermatology Drugs for Pets Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Dermatology Drugs for Pets Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Dermatology Drugs for Pets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Dermatology Drugs for Pets Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bayer Animal Health Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Animal Health Dermatology Drugs for Pets Product Offered
Table 95. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Bayer Animal Health Main Business
Table 97. Bayer Animal Health Latest Developments
Table 98. Boehringer Ingelheim Vetmedica Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 99. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Product Offered
Table 100. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Boehringer Ingelheim Vetmedica Main Business
Table 102. Boehringer Ingelheim Vetmedica Latest Developments
Table 103. Ceva Sante Animale Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 104. Ceva Sante Animale Dermatology Drugs for Pets Product Offered
Table 105. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Ceva Sante Animale Main Business
Table 107. Ceva Sante Animale Latest Developments
Table 108. Zoetis Inc. Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 109. Zoetis Inc. Dermatology Drugs for Pets Product Offered
Table 110. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Zoetis Inc. Main Business
Table 112. Zoetis Inc. Latest Developments
Table 113. Elanco Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 114. Elanco Dermatology Drugs for Pets Product Offered
Table 115. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Elanco Main Business
Table 117. Elanco Latest Developments
Table 118. IDEXX Laboratories Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 119. IDEXX Laboratories Dermatology Drugs for Pets Product Offered
Table 120. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. IDEXX Laboratories Main Business
Table 122. IDEXX Laboratories Latest Developments
Table 123. Merial Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 124. Merial Dermatology Drugs for Pets Product Offered
Table 125. Merial Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Merial Main Business
Table 127. Merial Latest Developments
Table 128. Vetoquinol S.A.panies Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 129. Vetoquinol S.A.panies Dermatology Drugs for Pets Product Offered
Table 130. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Vetoquinol S.A.panies Main Business
Table 132. Vetoquinol S.A.panies Latest Developments
Table 133. Virbac S.A. Basic Information, Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors
Table 134. Virbac S.A. Dermatology Drugs for Pets Product Offered
Table 135. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Virbac S.A. Main Business
Table 137. Virbac S.A. Latest Developments
List of Figures
Figure 1. Picture of Dermatology Drugs for Pets
Figure 2. Dermatology Drugs for Pets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermatology Drugs for Pets Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Dermatology Drugs for Pets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Dermatology Drugs for Pets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antibiotics
Figure 10. Product Picture of Antifungal Drugs
Figure 11. Product Picture of Others
Figure 12. Global Dermatology Drugs for Pets Sales Market Share by Type in 2021
Figure 13. Global Dermatology Drugs for Pets Revenue Market Share by Type (2017-2022)
Figure 14. Dermatology Drugs for Pets Consumed in Pets Clinics
Figure 15. Global Dermatology Drugs for Pets Market: Pets Clinics (2017-2022) & (K Units)
Figure 16. Dermatology Drugs for Pets Consumed in Pets Hospitals
Figure 17. Global Dermatology Drugs for Pets Market: Pets Hospitals (2017-2022) & (K Units)
Figure 18. Dermatology Drugs for Pets Consumed in Others
Figure 19. Global Dermatology Drugs for Pets Market: Others (2017-2022) & (K Units)
Figure 20. Global Dermatology Drugs for Pets Sales Market Share by Application (2017-2022)
Figure 21. Global Dermatology Drugs for Pets Revenue Market Share by Application in 2021
Figure 22. Dermatology Drugs for Pets Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Dermatology Drugs for Pets Revenue Market Share by Company in 2021
Figure 24. Global Dermatology Drugs for Pets Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Dermatology Drugs for Pets Revenue Market Share by Geographic Region in 2021
Figure 26. Global Dermatology Drugs for Pets Sales Market Share by Region (2017-2022)
Figure 27. Global Dermatology Drugs for Pets Revenue Market Share by Country/Region in 2021
Figure 28. Americas Dermatology Drugs for Pets Sales 2017-2022 (K Units)
Figure 29. Americas Dermatology Drugs for Pets Revenue 2017-2022 ($ Millions)
Figure 30. APAC Dermatology Drugs for Pets Sales 2017-2022 (K Units)
Figure 31. APAC Dermatology Drugs for Pets Revenue 2017-2022 ($ Millions)
Figure 32. Europe Dermatology Drugs for Pets Sales 2017-2022 (K Units)
Figure 33. Europe Dermatology Drugs for Pets Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Dermatology Drugs for Pets Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Dermatology Drugs for Pets Revenue 2017-2022 ($ Millions)
Figure 36. Americas Dermatology Drugs for Pets Sales Market Share by Country in 2021
Figure 37. Americas Dermatology Drugs for Pets Revenue Market Share by Country in 2021
Figure 38. United States Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Dermatology Drugs for Pets Sales Market Share by Region in 2021
Figure 43. APAC Dermatology Drugs for Pets Revenue Market Share by Regions in 2021
Figure 44. China Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Dermatology Drugs for Pets Sales Market Share by Country in 2021
Figure 51. Europe Dermatology Drugs for Pets Revenue Market Share by Country in 2021
Figure 52. Germany Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Dermatology Drugs for Pets Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Dermatology Drugs for Pets Revenue Market Share by Country in 2021
Figure 59. Egypt Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Dermatology Drugs for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Dermatology Drugs for Pets in 2021
Figure 65. Manufacturing Process Analysis of Dermatology Drugs for Pets
Figure 66. Industry Chain Structure of Dermatology Drugs for Pets
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...